Fact checked byGina Brockenbrough, MA

Read more

February 10, 2024
1 min read
Save

Zimmer Biomet reports fourth-quarter, full-year 2023 financial results

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Zimmer Biomet released its fourth-quarter and full-year 2023 financial results.
  • The company reported increased net sales in both the fourth quarter and full year of 2023.

Zimmer Biomet Holdings Inc. has announced increased net sales for the fourth quarter and full year of 2023, according to its latest financial report.

Zimmer Biomet reported $1.94 billion in net sales for the fourth quarter of 2023, an increase of 6.3% from the prior year period. The company also reported $7.394 billion in net sales for the full year of 2023, an increase of 6.5% from 2022. In addition, the company reported net earnings of $419.2 million for the fourth quarter of 2023 and $1.024 billion for the full year.

Generic Industry News infographic
Zimmer Biomet released its fourth-quarter and full-year 2023 financial results.

“We are pleased to conclude a successful year with strong fourth-quarter results driven by consistent execution, including a healthy second-half growth profile,” Ivan Tornos, president and CEO of Zimmer Biomet, said in the release. “I’m confident in our ability to carry our 2023 momentum into 2024 and to create further value for our stakeholders. As we look ahead, we remain laser focused on our priorities to advance people and culture, achieve operational excellence and drive innovation and diversification to deliver on our mission,” Tornos added.